UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA

Clinical trials for UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug cocktail targets tough stomach cancers in early trial

Disease control Not yet recruiting

This early-phase trial tests a new drug called futibatinib combined with two standard cancer treatments (paclitaxel and ramucirumab) for people with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery. The main goal is to find the s…

Matched conditions: UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA

Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control

Last updated May 26, 2026 04:23 UTC

UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA

Get alerted when new UNRESECTABLE GASTROESOPHAGEAL JUNCTION CARCINOMA trials appear

New drug cocktail targets tough stomach cancers in early trial